Back to top
more

ColgatePalmolive (CL)

(Delayed Data from NYSE)

$99.04 USD

99.04
6,029,945

-0.93 (-0.93%)

Updated Oct 4, 2024 04:00 PM ET

After-Market: $98.65 -0.39 (-0.39%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 4% (10 out of 252)

Industry: Soap and Cleaning Materials

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Will Demand & Pricing Trends Aid PepsiCo's (PEP) Q3 Earnings?

by Zacks Equity Research

PepsiCo's (PEP) Q3 results are expected to have gained from strong demand, improved pricing, strength in its beverage and food businesses, and gains from cost- and revenue-management initiatives.

What Awaits Conagra Brands (CAG) as It Queues for Q1 Earnings?

by Zacks Equity Research

Conagra Brands' (CAG) first-quarter results are likely to reflect gains from the frozen and snacks categories. Solid pricing efforts are likely to aid amid cost inflation.

P&G (PG) Gains From Solid Product Portfolio, Pricing Actions

by Zacks Equity Research

Procter & Gamble (PG) stays afloat in a tough environment, thanks to its product portfolio, pricing actions, and productivity and cost-saving plans.

Ritujay Ghosh headshot

Consumer Confidence Plummets on Recession Fears: 5 Stocks to Buy

by Ritujay Ghosh

Consumer confidence is declining on recession fears. Defensive stocks like ALLETE (ALE), Consolidated Water (CWCO), American Water Works Company (AWK), Kimberly-Clark (KMB) and Colgate-Palmolive (CL) are safe bets.

Will Colgate's (CL) Innovation Efforts Boost Its Stock?

by Zacks Equity Research

Colgate (CL) suffers from rising raw material costs and inflation, as well as the impacts of pricing actions. Its innovation and expansion efforts place it well for growth in the long term.

The Zacks Analyst Blog Highlights Visa, Chubb, HCA Healthcare, Colgate-Palmolive and Veeva

by Zacks Equity Research

Visa, Chubb, HCA Healthcare, Colgate-Palmolive and Veeva are included in this Analyst Blog.

Sheraz Mian headshot

Top Stock Reports for Visa, Chubb & HCA Healthcare

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), Chubb Limited (CB) and HCA Healthcare, Inc. (HCA).

Can Its Growth Efforts Aid Colgate (CL) Amid Cost Woes?

by Zacks Equity Research

Despite rising raw material costs and adverse currency, Colgate's (CL) robust innovation, pricing efforts and expansion plans are likely to drive growth in the long term.

The Zacks Analyst Blog Highlights Visa, Novo Nordisk, Medtronic, Shopify and Colgate-Palmolive

by Zacks Equity Research

Visa, Novo Nordisk, Medtronic, Shopify and Colgate-Palmolive are included in this Analyst Blog.

Sheraz Mian headshot

Top Stock Reports for Visa, Novo Nordisk & Medtronic

by Sheraz Mian

Today's Research Daily features new research reports on 12 major stocks, including Visa Inc. (V), Novo Nordisk A/S (NVO) and Medtronic plc (MDT).

Zacks Industry Outlook Highlights Unilever, Church & Dwight, Procter & Gamble and Colgate-Palmolive

by Zacks Equity Research

Unilever, Church & Dwight, Procter & Gamble and Colgate-Palmolive have been highlighted in this Industry Outlook article.

Avisekh Bhattacharjee headshot

4 Soaps & Cleaning Materials Stocks to Gain as Industry Catches On

by Avisekh Bhattacharjee

The soap and cleaning materials industry benefits from revived demand trends, pricing actions, innovation, digital transformation and brand building. Players like UL, CHD, PG and CL look well-poised.

Colgate (CL) Q2 Earnings & Sales Surpass Estimates, View Up

by Zacks Equity Research

Colgate-Palmolive's (CL) second-quarter 2023 organic sales advance 8%, with improvements in all divisions and categories.

Procter & Gamble (PG) Rises on Q4 Earnings Beat, Robust View

by Zacks Equity Research

Procter & Gamble's (PG) Q4 results reflect strong gains from its pricing actions, robust demand, improved sales and margins, and a positive product mix.

Mark Vickery headshot

Pre-Markets Rebound After Selloff; PCE & Q2 Numbers Everywhere

by Mark Vickery

Year over year PCE headline came down to +3.0%, +4.1% on core. Still above the Fed's optimum inflation rate, but well off cycle highs.

Core PCE Inflation Drops to 2 - Year Low

by Zacks Equity Research

Core PCE Inflation Drops to 2 - Year Low

Colgate-Palmolive (CL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

Although the revenue and EPS for Colgate-Palmolive (CL) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Colgate-Palmolive (CL) Q2 Earnings and Revenues Top Estimates

by Zacks Equity Research

Colgate-Palmolive (CL) delivered earnings and revenue surprises of 2.67% and 3.23%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Shaun Pruitt headshot

Top-Rated Stocks to Watch as Earnings Approach

by Shaun Pruitt

Investors should pay attention to other sectors outside of Energy on Friday as there appears to be opportunity in these Consumer Staples and Auto sector stocks.

Should You Buy Colgate-Palmolive (CL) Ahead of Earnings?

by Zacks Equity Research

Colgate-Palmolive (CL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Factors to Note Ahead of Panasonic's (PCRFY) Q1 Earnings

by Zacks Equity Research

Amid macro-economic turmoil, Panasonic's (PCRFY) first-quarter fiscal 2024 performance is likely to have been cushioned by continued momentum in sales of A2W products in Europe.

Colgate (CL) to Report Q2 Earnings: What's in the Offing?

by Zacks Equity Research

Colgate's (CL) second-quarter 2023 sales are likely to have benefited from strong demand for its products, innovation, brand strength and a focus on premiumization. Rising costs and expenses might have hurt its margins.

Clorox (CLX) Gains From Digital Initiatives & Pricing Power

by Zacks Equity Research

Clorox's (CLX) IGNITE strategy serves as a catalyst for driving innovation, enhancing operational efficiency and bolstering international growth.

Procter & Gamble (PG) Widens Spectrum on Value Creation

by Zacks Equity Research

Procter & Gamble (PG) advances the execution of the integrated strategies -- Supply Chain initiatives and digital penetration to strengthen the organization.

Derek Lewis headshot

3 Stocks to Buy for Decreased Volatility

by Derek Lewis

With CPI looming, investors may want to visit low-beta stocks as a shield against volatility. As we all know by now, CPI days have become quite a market-moving event.